Atomoxetine, marketed under the brand name Strattera, is a medication primarily used in the treatment of attention-deficit hyperactivity disorder (ADHD). Unlike many other ADHD medications, atomoxetine is a non-stimulant. It is approved for use in children, adolescents, and adults. Its action involves affecting specific neurochemicals in the brain, leading to improvements in attention span, hyperactivity, and impulsivity. As a non-controlled substance, it may be an option for individuals who do not respond well to stimulants or experience significant side effects from them, or for those with co-occurring conditions that preclude stimulant use. (Source: DrugBank, MedlinePlus)
Deep dive
Tap a section to expand.
Known interactions
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Category rule: vitamin × medication
Note
Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).
Specific pairs are checked against a licensed source; confirm with your provider.
Frequently asked
Sources referenced
- Cochrane
- DrugBank
- European Medicines Agency (EMA) SmPC
- FDA label
- Mayo Clinic
- MedlinePlus
- National Institutes of Health (NIH) - National Library of Medicine
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the medication category or studied for the same goals.
